Suppr超能文献

遗传性血色素沉着症蛋白HFE与转铁蛋白受体2的相互作用是转铁蛋白诱导的铁调素表达所必需的。

Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression.

作者信息

Gao Junwei, Chen Juxing, Kramer Maxwell, Tsukamoto Hidekazu, Zhang An-Sheng, Enns Caroline A

机构信息

Department of Cell and Developmental Biology, Oregon Health & Science University, Portland, OR 97239, USA.

出版信息

Cell Metab. 2009 Mar;9(3):217-27. doi: 10.1016/j.cmet.2009.01.010.

Abstract

The mechanisms that allow the body to sense iron levels in order to maintain iron homeostasis are unknown. Patients with the most common form of hereditary iron overload have mutations in the hereditary hemochromatosis protein HFE. They have lower levels of hepcidin than unaffected individuals. Hepcidin, a hepatic peptide hormone, negatively regulates iron efflux from the intestines into the blood. We report two hepatic cell lines, WIF-B cells and HepG2 cells transfected with HFE, where hepcidin expression responded to iron-loaded transferrin. The response was abolished when endogenous transferrin receptor 2 (TfR2) was suppressed or in primary hepatocytes lacking either functional TfR2 or HFE. Furthermore, transferrin-treated HepG2 cells transfected with HFE chimeras containing only the alpha3 and cytoplasmic domains could upregulate hepcidin expression. Since the HFE alpha3 domain interacts with TfR2, these results supported our finding that TfR2/HFE complex is required for transcriptional regulation of hepcidin by holo-Tf.

摘要

机体用以感知铁水平以维持铁稳态的机制尚不清楚。最常见的遗传性铁过载患者,其遗传性血色素沉着症蛋白HFE存在突变。他们的铁调素水平低于未受影响的个体。铁调素是一种肝脏肽类激素,对铁从肠道向血液的外排起负调节作用。我们报告了两种肝细胞系,即转染了HFE的WIF-B细胞和HepG2细胞,其中铁调素表达对铁负载的转铁蛋白有反应。当内源性转铁蛋白受体2(TfR2)被抑制时,或者在缺乏功能性TfR2或HFE的原代肝细胞中,这种反应消失。此外,用仅含α3和胞质结构域的HFE嵌合体转染的转铁蛋白处理的HepG2细胞,可上调铁调素表达。由于HFE的α3结构域与TfR2相互作用,这些结果支持了我们的发现,即TfR2/HFE复合物是全转铁蛋白对铁调素进行转录调控所必需的。

相似文献

2
The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression.
Cell Metab. 2008 Mar;7(3):205-14. doi: 10.1016/j.cmet.2007.11.016.
3
Hepatocyte-targeted HFE and TFR2 control hepcidin expression in mice.
Blood. 2010 Apr 22;115(16):3374-81. doi: 10.1182/blood-2009-09-245209. Epub 2010 Feb 22.
4
Disruption of hemochromatosis protein and transferrin receptor 2 causes iron-induced liver injury in mice.
Hepatology. 2012 Aug;56(2):585-93. doi: 10.1002/hep.25689. Epub 2012 Jun 11.
5
Iron regulation of hepcidin despite attenuated Smad1,5,8 signaling in mice without transferrin receptor 2 or Hfe.
Gastroenterology. 2011 Nov;141(5):1907-14. doi: 10.1053/j.gastro.2011.06.077. Epub 2011 Jul 13.
6
Transgenic HFE-dependent induction of hepcidin in mice does not require transferrin receptor-2.
Am J Hematol. 2012 Jun;87(6):588-95. doi: 10.1002/ajh.23173. Epub 2012 Mar 28.
7
The hemochromatosis proteins HFE, TfR2, and HJV form a membrane-associated protein complex for hepcidin regulation.
J Hepatol. 2012 Nov;57(5):1052-60. doi: 10.1016/j.jhep.2012.06.015. Epub 2012 Jun 21.
8
Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6.
Proc Natl Acad Sci U S A. 2006 Jul 5;103(27):10289-10293. doi: 10.1073/pnas.0603124103. Epub 2006 Jun 26.

引用本文的文献

2
HFE-Related Hemochromatosis May Be a Primary Kupffer Cell Disease.
Biomedicines. 2025 Mar 10;13(3):683. doi: 10.3390/biomedicines13030683.
4
Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects.
Signal Transduct Target Ther. 2024 Oct 14;9(1):271. doi: 10.1038/s41392-024-01969-z.
6
Breaking the Barriers of Therapy Resistance: Harnessing Ferroptosis for Effective Hepatocellular Carcinoma Therapy.
J Hepatocell Carcinoma. 2024 Jul 2;11:1265-1278. doi: 10.2147/JHC.S469449. eCollection 2024.
7
TGF-β-regulated different iron metabolism processes in the development and cisplatin resistance of ovarian cancer.
Oncol Res. 2023 Dec 28;32(2):373-391. doi: 10.32604/or.2023.031404. eCollection 2023.
8
Nutritional Modulation of Hepcidin in the Treatment of Various Anemic States.
Nutrients. 2023 Dec 12;15(24):5081. doi: 10.3390/nu15245081.
9
Mechanisms controlling cellular and systemic iron homeostasis.
Nat Rev Mol Cell Biol. 2024 Feb;25(2):133-155. doi: 10.1038/s41580-023-00648-1. Epub 2023 Oct 2.
10
Overview of Ankle Arthropathy in Hereditary Hemochromatosis.
Med Sci (Basel). 2023 Aug 15;11(3):51. doi: 10.3390/medsci11030051.

本文引用的文献

1
The hereditary hemochromatosis protein, HFE, inhibits iron uptake via down-regulation of Zip14 in HepG2 cells.
J Biol Chem. 2008 Aug 1;283(31):21462-8. doi: 10.1074/jbc.M803150200. Epub 2008 Jun 4.
3
The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression.
Cell Metab. 2008 Mar;7(3):205-14. doi: 10.1016/j.cmet.2007.11.016.
4
A modified method for PCR-directed gene synthesis from large number of overlapping oligodeoxyribonucleotides.
J Biochem Biophys Methods. 2008 Apr 24;70(6):820-2. doi: 10.1016/j.jprot.2007.12.009. Epub 2008 Jan 9.
5
Hfe acts in hepatocytes to prevent hemochromatosis.
Cell Metab. 2008 Feb;7(2):173-8. doi: 10.1016/j.cmet.2007.11.014.
6
JAM-A is both essential and inhibitory to development of hepatic polarity in WIF-B cells.
Am J Physiol Gastrointest Liver Physiol. 2008 Feb;294(2):G576-88. doi: 10.1152/ajpgi.00159.2007. Epub 2007 Dec 20.
7
Regulation of iron acquisition and storage: consequences for iron-linked disorders.
Nat Rev Mol Cell Biol. 2008 Jan;9(1):72-81. doi: 10.1038/nrm2295.
9
Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4.
Blood. 2007 Sep 15;110(6):2182-9. doi: 10.1182/blood-2007-04-087593. Epub 2007 May 31.
10
Effect of phlebotomy on hepcidin expression in hemojuvelin-mutant mice.
Blood Cells Mol Dis. 2007 Jul-Aug;39(1):92-5. doi: 10.1016/j.bcmd.2007.02.004. Epub 2007 Mar 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验